NASDAQ : MODD
Modular Medical, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 1.72 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.02M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 8.08M | 7.59M | 4.35M | 4.65M | 4.82M | 7.20M |
| Research & Development | 19.21M | 19.97M | 14.70M | 12.88M | 9.06M | 7.73M |
| Operating Expenses | 27.29M | 27.56M | 19.05M | 17.53M | 13.88M | 14.93M |
| Operating Income | -27.29M | -27.56M | -19.05M | -17.53M | -13.88M | -14.93M |
| Interest Expense | -2.75M | |||||
| Other Non Operating Income (Expenses) | -730.00K | -680.00K | 226.00K | 61.00K | 1.00K | 368.92K |
| EBT Excluding Unusual Items | -28.02M | -28.24M | -18.82M | -17.47M | -13.88M | -17.31M |
| Other Unusual Items | -1.32M | |||||
| Pretax Income | -28.02M | -28.24M | -18.82M | -17.47M | -13.88M | -18.63M |
| Income Tax Expense | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K | 1.60K |
| Net Income | -28.03M | -28.24M | -18.82M | -17.47M | -13.88M | -18.63M |
| Net Income to Common | -28.03M | -28.24M | -18.82M | -17.47M | -13.88M | -18.63M |
| Shares Outstanding (Basic) | 3.20M | 2.29M | 1.23M | 745.90K | 403.43K | 226.92K |
| Shares Outstanding (Diluted) | 3.20M | 2.29M | 1.23M | 745.90K | 403.43K | 226.92K |
| EPS (Basic) | -8.77 | -12.36 | -15.27 | -23.42 | -34.40 | -82.11 |
| EPS (Diluted) | -8.77 | -12.36 | -15.27 | -23.42 | -34.40 | -82.11 |
| Free Cash Flow | -28.04M | -27.68M | -18.21M | -15.65M | -12.65M | -10.31M |
| Free Cash Flow Per Share | -8.78 | -12.12 | -14.77 | -20.98 | -31.35 | -45.45 |
| EBITDA | -25.53M | -25.89M | -17.98M | -17.10M | -13.73M | -14.81M |
| D&A For EBITDA | 1.76M | 1.67M | 1.06M | 426.00K | 152.00K | 117.49K |
| EBIT | -27.29M | -27.56M | -19.05M | -17.53M | -13.88M | -14.93M |
Balance sheet
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.92M | 6.94M | 13.10M | 9.23M | 3.80M | 9.08M |
| Cash & Short-Term Investments | 3.92M | 6.94M | 13.10M | 9.23M | 3.80M | 9.08M |
| Other Receivables | 239.00K | 17.00K | 70.00K | |||
| Receivables | 239.00K | 17.00K | 70.00K | |||
| Prepaid Expenses | 686.00K | 583.00K | 352.00K | 465.00K | 147.00K | 313.42K |
| Other Current Assets | 100.00K | |||||
| Total Current Assets | 4.84M | 7.54M | 13.52M | 9.70M | 4.05M | 9.39M |
| Property, Plant & Equipment | 7.35M | 7.23M | 5.22M | 4.11M | 3.20M | 356.65K |
| Other Long-Term Assets | 61.00K | 61.00K | 100.00K | |||
| Total Assets | 12.25M | 14.83M | 18.73M | 13.81M | 7.25M | 9.85M |
| Accounts Payable | 604.00K | 992.00K | 338.00K | 802.00K | 285.00K | 299.95K |
| Accrued Expenses | 607.00K | 488.00K | 504.00K | 280.00K | 339.00K | 524.89K |
| Current Portion of Leases | 278.00K | 393.00K | 423.00K | 373.00K | 355.00K | 144.86K |
| Total Current Liabilities | 1.49M | 1.87M | 1.26M | 1.46M | 979.00K | 969.70K |
| Long-Term Leases | 393.00K | 817.00K | 1.19M | 39.96K | ||
| Total Liabilities | 1.49M | 1.87M | 1.66M | 2.27M | 2.17M | 1.01M |
| Common Stock | 6.00K | 5.00K | 2.00K | 32.00K | 11.00K | 10.46K |
| Additional Paid-In Capital | 130.11M | 125.95M | 101.83M | 77.43M | 53.52M | 43.41M |
| Retained Earnings | -119.48M | -113.00M | -84.75M | -65.93M | -48.46M | -34.58M |
| Comprehensive Income & Other | 128.00K | |||||
| Shareholders' Equity | 10.76M | 12.96M | 17.08M | 11.54M | 5.08M | 8.84M |
| Total Liabilities & Equity | 12.25M | 14.83M | 18.73M | 13.81M | 7.25M | 9.85M |
| Total Debt | 278.00K | 393.00K | 816.00K | 1.19M | 1.54M | 184.81K |
| Net Cash (Debt) | 3.64M | 6.55M | 12.28M | 8.04M | 2.25M | 8.89M |
| Net Cash Per Share | 1.14 | 2.87 | 9.96 | 10.78 | 5.59 | 39.18 |
| Filing Date Shares Outstanding | 8.15M | 5.41M | 1.81M | 1.08M | 702.96K | 363.72K |
| Total Common Shares Outstanding | 5.57M | 4.66M | 1.79M | 1.08M | 364.98K | 348.73K |
| Working Capital | 3.36M | 5.67M | 12.25M | 8.24M | 3.07M | 8.42M |
| Book Value Per Share | 1.93 | 2.78 | 9.54 | 10.66 | 13.91 | 25.34 |
| Tangible Book Value | 10.76M | 12.96M | 17.08M | 11.54M | 5.08M | 8.84M |
| Tangible Book Value Per Share | 1.93 | 2.78 | 9.54 | 10.66 | 13.91 | 25.34 |
| Machinery | 9.85M | 8.60M | 5.42M | 3.34M | 949.00K | 346.36K |
| Construction In Progress | 936.00K | 1.46M | 685.00K | 283.00K | 1.00M | |
| Leasehold Improvements | 33.00K | 33.00K | 33.00K | 33.00K | 25.00K | 139.20K |
Cash flow statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -28.03M | -28.24M | -18.82M | -17.47M | -13.88M | -18.63M |
| Depreciation & Amortization | 1.76M | 1.67M | 1.06M | 426.00K | 355.00K | 196.92K |
| Other Amortization | 1.83M | |||||
| Loss (Gain) From Sale of Assets | 21.00K | |||||
| Stock-Based Compensation | 1.51M | 1.79M | 2.43M | 2.72M | 2.93M | 4.43M |
| Other Operating Activities | 833.00K | 834.00K | 1.00K | -355.00K | -200.00K | 1.49M |
| Change in Accounts Payable | -362.00K | 453.00K | -288.00K | 458.00K | -200.00K | 354.95K |
| Change in Other Net Operating Assets | -73.00K | -259.00K | -104.00K | 248.00K | -14.00K | 65.65K |
| Operating Cash Flow | -24.35M | -23.75M | -15.72M | -13.95M | -11.01M | -10.26M |
| Capital Expenditures | -3.69M | -3.93M | -2.49M | -1.70M | -1.64M | -54.76K |
| Investing Cash Flow | -3.69M | -3.93M | -2.49M | -1.70M | -1.64M | -54.76K |
| Short-Term Debt Issued | 250.00K | 6.24M | ||||
| Total Debt Issued | 250.00K | 250.00K | 6.24M | |||
| Short-Term Debt Repaid | -250.00K | -2.10M | ||||
| Total Debt Repaid | -250.00K | -250.00K | -2.10M | |||
| Net Debt Issued (Repaid) | 4.14M | |||||
| Issuance of Common Stock | 20.49M | 17.56M | 22.08M | 21.09M | 7.37M | 13.79M |
| Other Financing Activities | 3.95M | 3.97M | ||||
| Financing Cash Flow | 24.44M | 21.53M | 22.08M | 21.09M | 7.37M | 17.92M |
| Net Cash Flow | -3.60M | -6.15M | 3.86M | 5.43M | -5.28M | 7.61M |
| Free Cash Flow | -28.04M | -27.68M | -18.21M | -15.65M | -12.65M | -10.31M |
| Free Cash Flow Per Share | -8.78 | -12.12 | -14.77 | -20.98 | -31.35 | -45.45 |
| Levered Free Cash Flow | -17.97M | -17.24M | -11.08M | -9.27M | -7.19M | -4.55M |
| Unlevered Free Cash Flow | -17.97M | -17.24M | -11.08M | -9.27M | -7.19M | -4.67M |
| Cash Interest Paid | 30.00K | 30.00K | 262.00K | |||
| Cash Income Tax Paid | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K | 1.60K |
| Change in Working Capital | -435.00K | 194.00K | -392.00K | 706.00K | -214.00K | 420.60K |
Ratios
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 14.67M | 24.61M | 57.94M | 57.33M | 15.85M | 46.80M |
| Enterprise Value | 11.03M | 22.17M | 51.87M | 56.56M | 8.24M | 53.80M |
| Last Close Price | 1.72 | 5.28 | 32.70 | 55.50 | 43.50 | 132.00 |
| PB Ratio | 0.89 | 1.90 | 3.39 | 4.97 | 3.12 | 5.30 |
| P/TBV Ratio | 1.40 | 1.90 | 3.39 | 4.97 | 3.12 | 5.30 |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.05 | 0.10 | 0.30 | 0.02 |
| Net Debt / Equity Ratio | -0.34 | -0.51 | -0.72 | -0.70 | -0.44 | -1.01 |
| Net Debt / EBITDA Ratio | 0.14 | 0.25 | 0.68 | 0.47 | 0.16 | 0.60 |
| Net Debt / FCF Ratio | 0.13 | 0.24 | 0.67 | 0.51 | 0.18 | 0.86 |
| Quick Ratio | 2.79 | 3.71 | 10.41 | 6.34 | 3.88 | 9.36 |
| Current Ratio | 3.25 | 4.03 | 10.69 | 6.67 | 4.13 | 9.68 |
| Return on Equity (ROE) | -247.94% | -188.05% | -131.58% | -210.34% | -199.51% | -492.82% |
| Return on Assets (ROA) | -129.12% | -102.63% | -73.17% | -104.08% | -101.50% | -154.27% |
| Return on Capital Employed (ROCE) | -253.60% | -212.70% | -109.00% | -141.90% | -221.50% | -168.20% |
| Earnings Yield | -487.25% | -114.77% | -32.49% | -30.47% | -87.56% | -39.81% |
| FCF Yield | -186.13% | -112.51% | -31.43% | -27.30% | -79.80% | -22.04% |
| Buyback Yield / Dilution | -127.74% | -85.32% | -65.30% | -84.89% | -77.78% | -9.60% |